Suerte, Jemar Jr. E.
HRN: 23-62-05 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/01/2023
AMPICILLIN 500MG (VIAL)
09/01/2023
09/08/2023
IV
200mg
Q6hours
URTI
Waiting Final Action
Indication: Empiric Type of Infection: URTI Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes